This is the FIRST live streamed only, three day professional conference discussing Cellular Therapies. We have gathered together invited speakers from around the world, who you might not otherwise have access to.
Abstracts for poster presentation only can be submitted up to 2nd September 2016
The Deadline for abstract submissions for oral presentation is 30th August 2016
From basic research to clinical practice, this multi-disciplinary event provides an opportunity to share and compare research progress and clinical experiences to establish reliable cellular therapies.
Who Should Attend: Anyone with an interest in cellular therapies, stem cell transplantation or regenerative medicine will find this event useful. Our events are multi-disciplinary and our delegates include academic researchers, clinicians and people from the pharmaceutical industry.
We encourage questions, discussion and debate and have a relaxed atmosphere which generates maximum interaction online.
After registration you will be connected to an online networking site where you will be able to have discussions with all participants of this event, before, during and after the meeting.
The event will be recorded and available for all registered delegates up to a month after the event. So if you can’t manage all the days, or the different time zones, you can still have access to the full event.
Invited speakers and their talks include:
|Why Cell Therapy Needs an Extracellular Matrix: Hydrogels for the Clinic||Professor Glenn D. Prestwich||The University of Utah||United States|
|Hemopoietic Stem Cell Transplantation in the Era of Personalized Medicine||Dr Arnold Ganser||Hannover Medical School||Germany|
|ErbB retargeted CAR T-cell immunotherapy of head and neck cancer||Dr John Maher||King's College Hospital||London, United|
|Experimental and clinical airway restoration by mesenchymal stromal cell endoscopic transplantation||Dr Francesco Petrella||Istituto Europeo di Oncologia||Italy|
|A Novel Method for Deriving Neuronal Progenitors for Parkinson’s Disease Therapy||Associate Professor Yiling Hong||Western University of Health Sciences||United States|
|The fate of intravenously injected mesenchymal stromal/stem cells||Dr. Reinhard Henschler||Blood Center Zurich||Switzerland|
|Stem Cell Therapies: A Regulatory Scientific Approach for Successful Translation into the Clinic||Dr Houria Bachtarzi||ERA Consulting (UK) Ltd||United Kingdom|
|Vector manufacturing for stem cell and other cell therapy purposes||Dr. Klaus Kühlcke||EUFETS GmbH||Germany|
|The role of the immune system in enhancing the homing and engraftment of stem cells to the heart after myocardial infarction: Potential therapeutic targets for regenerative therapy||Professor Ahmed Abdel-Latif||University of Kentucky||United States|
|Talk title to be confirmed||Dr. Oliver Pullig||Fraunhofer-Institute Interfacial Engineering and Biotechnology||Germany|
|Restoring immune competence after allogeneic stem cell transplantation: A double edged sword||Dr Martin Guimond||Maisonneuve-Rosemont Hospital||Canada|
|Talk title to be confirmed||Omar El-Shaarawy||.||Egypt|
|Towards optimising the use of umbilical cord blood for immunotherapy||Dr Aurore Saudemont||Anthony Nolan||United Kingdom|
|Talk title to be confirmed||Dr. Jo-Anna Reems||University of Utah School of Medicine||United States|
|The leukaemic stem cell niche and its possible therapeutic targeting||Professor Daniela Krause||Georg-Speyer-Haus||Germany|
|Sex, stem cells and regenerative medicine||Dr. Kirsten McEwen||Imperial College London||United Kingdom|
|CXCR4 knockdown in hematopoietic stem cells as a cure strategy for WHIM syndrome immunodeficiency||Dr. Philip M. Murphy||National Institute of Allergy and Infectious Diseases||United States|
|Immune-senescence and immune-exhaustion in hematopoietic stem cell transplantation and adoptive immunotherapy||Dr. Federico Simonetta||University of Geneva||Switzerland|
|Talk title to be confirmed||Dr. Sohel Talib||California Institute for Regenerative Medicine||United States|
|Human amniocytes as a countermeasure to osteopenia in a mouse model of fragile bones.||Dr. Pascale V Guillot||University College London||United Kingdom|
|Talk title to be confirmed||Professor Hala Gali-Muhtasib||American University of Beirut||Lebanon|
|Adipose-derived stem cell seeded biominerizable nanocomposite for chest wall repair: suppression of inflammatory response in a murine model||Dr. Johanna Buschmann||University Hospital Zurich||Switzerland|
|Functionalized carbon nanotubes in the ex vivo expansion of hematopoietic stem & progenitor cells||Associate Professor and Assistant Head Gigi Chiu Ngar Chee||National University of Singapore||Singapore|
|A holistic approach to MSC culture process design||Dr. Karen Coopman||Loughborough University||United Kingdom
|Finally, a method to determine stem cell dose for stem cell transplantation medicine||Dr James L. Sherley, M.D., Ph.D.||Asymmetrex, LLC||United States|
A Euroscicon live streamed event gives you access to a wider range of international speakers at a fraction of the cost of a real world event. Furthermore, you no longer have to worry about travel or accommodation expenses, or any arrangements you have which clash with our events.
Moving Forward with Stem Cell Therapy has an open abstract session:
Abstracts can be submitted on any subject related to Stem cell biology or Stem cell or Cellular therapies
Advisory Board Members
|Dr. Daniel Peterson||Rosalind Franklin University of Medicine and Science||United States|
|Dr Cornelia Kasper||University of Natural Resources and Life||Austria|
|Credits from The Institute of Biomedical Science (code)||Approved by the Royal Society of Biology for purposes of CPD|
|18(MS010N16)||This event may be counted as 54 CPD credits|